How will Pharmacogenomics look in 2020? Is your company sufficiently prepared? Join FDA regulatory attorney Darshan Kulkarni as he discusses how pharmacogenomics may change in 2020, and whether your clinical trials may be affected.
Pharmacy has undergone a series of changes in 2019. What might this mean for the future of pharmacy? In this episode, Darshan talks about how the rise in cannabis, telepharmacy, and the emergence of the General Data Protection Regulation (GDPR) may...
Pharmacogenomics is the study of how a person's genes affect how he or she responds to medication. Pharmacogenomic testing, however, remains medically necessary in very few cases. How has the increased use of genetic testing led the federal...
In today's episode, I sat with Trishna Bharadia to discuss solutions to issues around informed consent.
In today's episode, I sat with Trishna Bharadia to discuss operational engagement with patient advocates.
Francesca Rothseid, Esq. and I sit down to discuss pharmacists and how best to engage with patients in the context of better communciations.